Proactive Investors - Run By Investors For Investors

Iofina restructures its debt

Iofina said the extension of the debt, along with the removal of the convertibility of the notes, is an important step for the company
One of Iofina's extraction plants
Iofina specialises in the exploration and production of iodine, halogen-based speciality chemical derivatives and produced water

Iofina PLC (LON:IOF), the iodine extraction technology specialist, is to restructure its issued convertible loan notes and has also agreed to restructure the term loan facility provided by Stena Investment.

With the agreement of its convertible loan note holders, Iofina has extended the repayment term of the loan by 13 months to 1 July 2020.

READ: Iofina continues in record-busting form

The convertible element of the notes has been removed and the coupon has been increased from 5% to 7.5%, with the new rate kicking in as from 1 January of this year.

As for the term loan, this has also been extended to 1 July 2020, with the interest rate adjusted to 7.5% from the beginning of this year, rising to 12% on 1 June of this year.

Iofina said debt as at the end of 2018, comprised roughly U$22.37mln of loan notes and US$3.26mln owed to Stena Investment.

Positive for shareholders

Dr Tom Becker, the president and chief executive officer of Iofina said: ''Extending the terms of the notes and facility to 1 July 2020 will allow us to continue upgrading and expanding our plants, which in turn will further boost the level of Iodine production. At the same time, the removal of the debt convertibility is a huge positive for our shareholders. With iodine prices continuing to rise we are well positioned to continue the momentum built over the last few years."

In a note to clients, analysts at ‘house’ broker finnCap commented: “Iofina will incur a higher interest rate as a result and can no longer capitalise interest payments, although this still looks the best outcome that could have been expected and removes a major issue that has been weighing on the shares. In our forecasts we have delayed the assumed IOsorb plant expansions by 6-9 months, which reduces our EBITDA forecasts by 11-12%.”

They added: “This sees our DCF-based price target fall 3% to 34p. Nevertheless, Iofina still offers material upside and strong leverage to improving iodine prices and its continued operational recovery.”

In afternoon trading, shares in Iofina were 1.3% lower at 17.50p.

 -- Adds analyst comment, share price --

View full IOF profile View Profile

Iofina PLC Timeline

February 12 2019

Related Articles

oil well
May 02 2019
US Oil & Gas has submitted an application to frack the Eblana-3 well along with a hydrogeology report.
March 26 2019
The large scale uranium project has the potential to support a long life mining operation, with near surface, high-grade deposits for very low operating costs
February 15 2019
ExxonMobil has made ten discoveries on the neighbouring Stabroek Block with an estimated 5bn barrels of oil

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use